Intel's $11 Billion Quarter: When Blowout Growth Isn't Enough

Intel's best quarterly growth since 2011 fails to lift shares as foundry losses and rising capex fuel investor skepticism.

The market's relationship with Intel has entered an unusual phase: the company delivers its best numbers in years, and investors respond by selling the stock. That disconnect — not the earnings themselves — has become the defining narrative of the chipmaker's recent slide.

Since touching a 52-week high of €124.58 in late June, Intel shares have shed roughly 37 percent of their value. The monthly decline stands at nearly 30 percent, with Friday's close at €78.42 marking a 0.78 percent drop on the day and a 3.45 percent slide for the week. Yet zoom out twelve months, and the picture flips dramatically: the stock remains up more than 350 percent from its August 2025 trough of €16.69.

That contrast captures the tension at the heart of Intel's current predicament. This is no longer a beaten-down chipmaker being punished for weak results. It's a company being graded on a curve so steep that even strong execution no longer moves the needle.

The Numbers That Should Have Lifted the Stock

Intel's second-quarter 2026 results, reported recently, were objectively impressive. Revenue came in at $16.1 billion, a 25 percent year-over-year jump — the fastest single-quarter growth the company has posted since 2011. Management's forward guidance also topped analyst expectations, and the stock initially rose in after-hours trading.

Then the next trading day arrived, and the gains evaporated.

The reversal speaks to how dramatically expectations have shifted. Intel, long dismissed as a legacy chipmaker past its prime, is now being held to a standard few semiconductor companies could meet in this investment cycle: near-flawless execution. The market isn't rewarding improvement anymore. It's demanding perfection.

The Foundry Problem Won't Go Away

Beneath the headline growth numbers sits the real source of investor anxiety: Intel's foundry division. The segment posted an operating loss of roughly $2.1 billion in the second quarter, and external customers still account for only about 5 percent of total foundry revenue.

There are signs of progress. Reports indicate Intel is in talks with a South Korean memory-chip maker about a partnership involving the $28 billion New Albany facility. Apple has already been confirmed as a customer. But one anchor client — or even two — doesn't justify a capital expenditure program of this magnitude.

The company raised its 2026 capex forecast from $18 billion to more than $20 billion, and management has signaled "significantly higher" spending for 2027. Meanwhile, the quarter produced a GAAP net loss of $11 billion. That's the arithmetic giving investors pause: growth on the surface, cash burn underneath.

A Market Caught Between Fear and Conviction

The technical picture reflects this ambivalence. Intel trades about 20 percent below its 50-day moving average of €98.65 and has slipped under the 100-day average at €81.52. The RSI sits at 39.2 — approaching oversold territory without yet signaling a clear bottom. Annualized volatility of roughly 78 percent underscores just how jittery trading has become.

Yet the longer-term trend line remains intact. The stock still holds about 34 percent above its 200-day moving average, and the August 2025 uptrend hasn't been broken. That's cold comfort for recent buyers, but it suggests the correction — however painful — hasn't invalidated the broader recovery thesis.

Analysts remain split, and the consensus target of €100.45 implies roughly 28 percent upside from current levels. That average masks a deeply divided sell-side: some houses continue to defend the turnaround story, while others have trimmed targets, citing execution risk.

The Operating Story Is Improving — Slowly

For all the gloom, there are genuine signs of structural progress. Intel's operating margin has swung positive on a trailing twelve-month basis, reaching 7.6 percent versus negative 8.3 percent a year earlier. That's a real improvement, not a one-off artifact.

The market capitalization now stands near €400 billion — a figure that seemed almost unthinkable a year ago. The company has successfully reinvented its narrative from has-been to AI-era contender. But that new status brings new scrutiny, and the market's patience for the foundry strategy is finite.

The critical test ahead is the 18A manufacturing process. If Intel can successfully transition that technology into high-volume external production, the current discount to the year's high could look like a buying opportunity in hindsight. If not, the "foundry burn" label will only harden.

For now, the stock sits in an uncomfortable middle ground: too expensive to be a value play, too uncertain to be a momentum trade. The coming quarters will determine whether this correction was a healthy pause before the next leg up — or the first sign that the market's patience with Intel's capital-intensive bet is running out.